A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5 | Macular Diseases | JAMA Ophthalmology | JAMA Network
[Skip to Navigation]
Clinical Trial
September 14, 2009

A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5

The SCORE Study Research Group*
Author Affiliations

Authors/Writing Committee: Michael S. Ip, MD (Chair); Ingrid U. Scott, MD, MPH; Paul C. VanVeldhuisen, PhD; Neal L. Oden, PhD; Barbara A. Blodi, MD; Marian Fisher, PhD; Lawrence J. Singerman, MD; Michael Tolentino, MD; Clement K. Chan, MD; Victor H. Gonzalez, MD.

Arch Ophthalmol. 2009;127(9):1101-1114. doi:10.1001/archophthalmol.2009.234

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

×